Literature DB >> 28976498

Prophylactic ciprofloxacin for prostate biopsy: a losing bet?

Maxim Bloomfield1, Timothy Blackmore1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28976498     DOI： 10.1038/nrurol.2017.154

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  9 in total

1.  Best practice policy statement on urologic surgery antimicrobial prophylaxis.

Authors:  J Stuart Wolf; Carol J Bennett; Roger R Dmochowski; Brent K Hollenbeck; Margaret S Pearle; Anthony J Schaeffer
Journal:  J Urol       Date:  2008-02-20       Impact factor: 7.450

2.  CUA Guidelines on antibiotic prophylaxis for urologic procedures.

Authors:  Marko Mrkobrada; Ivan Ying; Stephanie Mokrycke; George Dresser; Sameer Elsayed; Varunkumar Bathini; Erin Boyce; Patrick Luke
Journal:  Can Urol Assoc J       Date:  2015 Jan-Feb       Impact factor: 1.862

3.  Sepsis: Prophylactic antibiotic for prostate biopsy: the carbapenem gamble.

Authors:  Deepak K Pruthi; Michael A Liss
Journal:  Nat Rev Urol       Date:  2017-05-23       Impact factor: 14.432

4.  Routine Ertapenem Prophylaxis for Transrectal Ultrasound Guided Prostate Biopsy does Not Select for Carbapenem Resistant Organisms: A Prospective Cohort Study.

Authors:  Maxim G Bloomfield; Matthew J Page; Alice G McLachlan; Rodney C Studd; Timothy K Blackmore
Journal:  J Urol       Date:  2017-03-10       Impact factor: 7.450

5.  Emergence of fluoroquinolone-resistant Escherichia coli as cause of postprostate biopsy infection: implications for prophylaxis and treatment.

Authors:  Osama M Zaytoun; Ethan H Vargo; Ramanathan Rajan; Ryan Berglund; Steven Gordon; J Stephen Jones
Journal:  Urology       Date:  2011-03-21       Impact factor: 2.649

6.  Antibiotic use and the risk of carbapenem-resistant extended-spectrum-{beta}-lactamase-producing Klebsiella pneumoniae infection in hospitalized patients: results of a double case-control study.

Authors:  Evangelos I Kritsotakis; Constantinos Tsioutis; Maria Roumbelaki; Athanasia Christidou; Achilleas Gikas
Journal:  J Antimicrob Chemother       Date:  2011-03-31       Impact factor: 5.790

7.  The incidence of fluoroquinolone resistant infections after prostate biopsy--are fluoroquinolones still effective prophylaxis?

Authors:  Joseph Feliciano; Ervin Teper; Michael Ferrandino; Richard J Macchia; William Blank; Ivan Grunberger; Ivan Colon
Journal:  J Urol       Date:  2008-01-22       Impact factor: 7.450

8.  Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae.

Authors:  Leanne B Gasink; Paul H Edelstein; Ebbing Lautenbach; Marie Synnestvedt; Neil O Fishman
Journal:  Infect Control Hosp Epidemiol       Date:  2009-12       Impact factor: 3.254

9.  Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case control study.

Authors:  Matthew E Falagas; Petros I Rafailidis; Diamantis Kofteridis; Simona Virtzili; Fotini C Chelvatzoglou; Vassiliki Papaioannou; Sofia Maraki; George Samonis; Argyris Michalopoulos
Journal:  J Antimicrob Chemother       Date:  2007-09-20       Impact factor: 5.790
  9 in total
  1 in total

1.  Rational antibiotic sustainability for transrectal prostate biopsy prophylaxis.

Authors:  Deepak K Pruthi; Michael A Liss
Journal:  Nat Rev Urol       Date:  2017-10-04       Impact factor: 14.432
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.